There have been the initial rumblings of a Pfizer reorganization, in terms of comments about Pfizer's decision to "externalize" some of its rare disease research and some vague comments from Pfizer's CEO about the importance of the organization's next 18 months.
A reliable source indicates that some layoffs have begun at one site on the research side, and possibly more on the way.
This is sad news. Unfortunately, a reality of Pfizer is that there has long been a pattern of regular reorganizations and waves of layoffs, and it's ~2019-2022 that has been the abnormal time. If true, I suppose the leadership is reverting to the mean.
Best wishes to those impacted, best wishes to the larger Pfizer organization as a whole, and to all of us.
